Skip to main content

Table 4 Preclinical trials of sEV-encapsulated ncRNAs as therapeutics in PDAC

From: Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications

Ref

sEV donor

Cargo loading

ncRNA

Mouse model

Therapeutic intervention

Result

Kamerkar et al. [193]

Human foreskin fibroblast

Electroporation

siKRASG12D

orthotopic PANC-1/BxPC-3/KPC689 xenografts

Intraperitoneal injection of sEVs

Prolonged survival, inhibition of metastasis

KPC/KTC GEMM

Mendt et al. [206]

BM-MSC

Electroporation

siKRASG12D

Orthotopic KPC689/PANC-1 xenograft

Intraperitoneal injection of sEVs

Prolonged survival, enhanced effect of gemcitabine

Orthotopic PATX-60 PDX

PKS GEMM

Ding et al. [201]

HUC-MSC

Transfection

miR-145-5p

mimic

Subcutaneous PANC-1

xenograft

Intratumoral injection of sEVs

Reduced tumor growth

Wu et al. [202]

BM-MSC

Transfection

miR-126-3p mimic

Subcutaneous xenograft

Co-injection of BM-MSCs

Reduced tumor growth

Shang et al. [204]

BM-MSC

Transfection

miR-1231

mimic

Subcutaneous BxPC-3 xenograft

Tail vein injection of sEVs

Reduced tumor growth

Zuo et al. [207]

HEK293

Ultrasound

miR-34a mimic

Subcutaneous Panc28 xenograft

Intravenous injection of sEVs

Reduced tumor growth

Xu et al. [208]

PANC-1

Electroporation

siPAK4

Subcutaneous PANC-1 xenograft

Intratumoral injection of sEVs

Reduced tumor growth

Zhou et al. [209]

BM-MSC

Electroporation

siGalectin9

Orthotopic PANC-02 xenograft

Tail vein injection of sEVs

Enhanced effect of immunotherapy

  1. 5-FU, fluorouracil; BM, bone marrow; GEMM, genetically engineered mouse model; HUC, human umbilical cord; MSC, mesenchymal stem cell; PDX, patient-derived xenograft; Ref., reference